Potential factors associated with cognitive improvement of individuals diagnosed with mild cognitive impairment or dementia in longitudinal studies

Manuscript Number: 

18-0101R3

Author(s): 
Roy M. Anderson, Frank De Wolf, Stephanie Evans, Christoforos Hadjichrysanthou, Kevin McRae-McKee

Disclosures

Roy M. Anderson

  • Consulting Fees:
    Oriole Global Health Ltd - work on infectious disease control
    Equity:
    18,250 shares in Glaxo Smith Kline - part of an investment portfolio
    Grants
    • Agency: 
      GSK, Janssen
      Dates: 
      June 2017-June 2018, June 2011-2018

Frank De Wolf

  • Equity:
    Sponsors:
    permanent contract with Janssen Pharmaceuticals of Johnson & Johnson

Stephanie Evans

  • Nothing to Disclose

Christoforos Hadjichrysanthou

  • Nothing to Disclose

Kevin McRae-McKee

  • Nothing to Disclose